Medical Device Outsourcing

If at the end of the last decade, most experts and work predicted that the outsourcing of certain services, call them secondary or non-strategic pharmaceutical industry, “biotech” food, institutional or scientific associations and societies would represent safeguarding benefits and progress of the sector, today, opinion leaders and experts in the field go further and announce a “cross fertilization” between different partners or companies is and will be the key to ensuring the huge growth expected for next years. We are talking about outsourcing procedures knowledge, something unthinkable a few years ago.